Amen Gopab. That will be very sweet. Say Novartis or Roche buys 200 million shares of PAB for $20 million. They pay 10 cents per share, but $ 20 million is petty cash for a major and they own 12% of the company which has the strong potential to cure cancer and also breach the brain barrier based on results in animals. They can then keep increasing their stake by buying on market. The market cap is still only $77 million.
Ann: Trading Halt, page-71
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
